First, subjects in former group had DHEAS levels (80 mcg/dl) much higher than those described in RA subjects (18 mcg/dl) [8] These were not RA patients (see exclusion criteria) and may never progress to overt RA. The gene discussed is SULT2A1; the disease is rheumatoid arthritis.